Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade · PMID 42321916
View analysis →A grade · PMID 42372741
View analysis →A grade · PMID 42216567
View analysis →A grade · PMID 42382416
View analysis →A grade · PMID 42150584
View analysis →A grade · PMID 42362103
View analysis →A grade · PMID 42101908
View analysis →A grade · PMID 42248607
View analysis →A grade · PMID 42296977
View analysis →A grade · PMID 42308229
View analysis →A grade · PMID 42032072
View analysis →A grade · PMID 42202757
View analysis →This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.4/100. Study design: 55.0; human relevance: 85.0; therapeutic relevance: 22.0; sample size: 20.0; recency: 100.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.4/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 64.3; sample size: 20.0; recency: 100.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 49.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 54.2; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 64.1; sample size: 20.0; recency: 100.0; abstract quality: 65.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 49.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 54.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 48.9; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.3/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 48.9; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.2/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 41.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.2/100. Study design: 30.0; human relevance: 80.0; therapeutic relevance: 46.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.2/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 41.0; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.1/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 48.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.1/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 48.0; sample size: 20.0; recency: 100.0; abstract quality: 85.0.
This pediatric cancer paper has not been AI summarized yet.
Deterministic evidence score: 56.1/100. Study design: 50.0; human relevance: 55.0; therapeutic relevance: 40.3; sample size: 20.0; recency: 100.0; abstract quality: 100.0.
